Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Respiratory Review Année : 2022

Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view

Sonya Craig
  • Fonction : Auteur
  • PersonId : 1136184
Jean-Louis Pépin
Winfried Randerath
Jerryll Asin
  • Fonction : Auteur
Ferran Barbé
  • Fonction : Auteur

Résumé

Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA), defined as the inability to stay awake during the day. Its clinical descriptors remain elusive, and the pathogenesis is complex, with disorders such as insufficient sleep and depression commonly associated. Subjective EDS can be evaluated using the Epworth Sleepiness Scale, in which the patient reports the probability of dozing in certain situations; however, its reliability has been challenged. Objective tests such as the multiple sleep latency test or the maintenance of wakefulness test are not commonly used in patients with OSA, since they require nocturnal polysomnography, daytime testing and are expensive. Drugs for EDS are available in the United States but were discontinued in Europe some time ago. For European respiratory physicians, treatment of EDS with medication is new and they may lack experience in pharmacological treatment of EDS, while novel wake-promoting drugs have been recently developed and approved for clinical use in OSA patients in the USA and Europe. This review will discuss 1) the potential prognostic significance of EDS in OSA patients at diagnosis, 2) the prevalence and predictors of residual EDS in treated OSA patients, and 3) the evolution of therapy for EDS specifically for Europe.
Fichier principal
Vignette du fichier
Craig S Residual sleepiness OSA Eur Respir Rev 2022.pdf (450.34 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03688773 , version 1 (05-06-2022)

Identifiants

Citer

Sonya Craig, Jean-Louis Pépin, Winfried Randerath, Christian Caussé, Johan Verbraecken, et al.. Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view. European Respiratory Review, 2022, 31, pp.210230. ⟨10.1183/16000617.0230-2021⟩. ⟨hal-03688773⟩

Collections

UGA
9 Consultations
57 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More